Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Oct-Dec;9(4):149-153.
doi: 10.4103/ijt.ijt_32_17.

Insignificant Correlation between Thyroid Hormone and Antithyroid Peroxidase Antibodies in Alopecia Areata Patients in Northern Rajasthan

Affiliations

Insignificant Correlation between Thyroid Hormone and Antithyroid Peroxidase Antibodies in Alopecia Areata Patients in Northern Rajasthan

Gagandeep Kaur et al. Int J Trichology. 2017 Oct-Dec.

Abstract

Background: Alopecia areata (AA) is a common, recurrent form of nonscarring alopecia which often presents as circumscribed patches of spontaneous hair loss. The global prevalence of this disease varies from 0.1% to 0.2% in general population and 7-30 cases per 1000 dermatological patients. The etiology of AA still remains uncertain; however, genetic or environmental factor and autoimmunity are claimed responsible for it. Various autoimmune diseases, such as Hashimoto's thyroiditis, diabetes mellitus, vitiligo, and lupus erythematosus, have been reported in association with AA.

Aim: The index study was aimed at estimation of serum T3, T4, thyroid-stimulating hormone, and antithyroid peroxidase (TPO) antibodies.

Material and methods: Similar age/sex-matched AA patients and controls (110 in each group). Enhanced chemiluminescence immunoassay for thyroid profile and anti-TPO antibody level estimation in veinous blood sample.

Observations: The mean/standard deviation (SD) of T3 was 3.30 ± 0.84 pg/ml in AA while 3.27 ± 0.67 pg/ml in controls (P = 0.302). Serum mean/SD of T4 level was1.23 ± 0.76 ng/dl in AA patients while 1.17 ± 0.34 ng/dl in controls (P = 0.522). The mean/SD of anti-TPO levels in AA patients was 21.52 ± 35.09 while 56.43 ± 140.72 in controls (P = 0.136).

Limitation: The limitation of this study was moderate number of AA patients and different genotype of study population.

Conclusion: Occurrence of thyroid dysfunction and evidence of anti-TPO antibodies in AA is rare event in this study population.

Keywords: Alopecia areata; thyroid hormone; thyroperoxidase antibody.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Patchy Alopecia over beard region
Figure 2
Figure 2
Alopecia totalis
Figure 3
Figure 3
Sisaipho
Figure 4
Figure 4
Ophiasis
Figure 5
Figure 5
Insignificant difference in T3 level in alopecia areata patients and controls (P = 0.302)
Figure 6
Figure 6
Serum T4 level in alopecia areata patients and controls (P = 0.522)
Figure 7
Figure 7
Distribution of antithyroid peroxidase antibody levels in alopecia areata cases and controls (P = 0.139 NS)

Similar articles

Cited by

References

    1. Bolduc C. Alopecia Areata. Medscape web portal: eMedicine. 2006:1–33.
    1. Safavi KH, Muller SA, Suman VJ, Moshell AN, Melton LJ., 3rd Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. Mayo Clin Proc. 1995;70:628–33. - PubMed
    1. Yang S, Yang J, Liu JB, Wang HY, Yang Q, Gao M, et al. The genetic epidemiology of alopecia areata in China. Br J Dermatol. 2004;151:16–23. - PubMed
    1. Dogra D, Sood A, Khaitan BK. Alopecia areata in identical twins. Indian J Dermatol Venereol Leprol. 1996;62:199. - PubMed
    1. Friedmann PS. Alopecia areata and auto-immunity. Br J Dermatol. 1981;105:153–7. - PubMed